current and emerging role of radiogenomics in risk assessment for focal therapy
Published 2 years ago • 263 plays • Length 11:43Download video MP4
Download video MP3
Similar videos
-
15:45
current and emerging role of radiogenomics in risk assessment for prostate cancer
-
16:41
current and emerging role of radiogenomics
-
10:50
urologic perspective on the current and emerging role of multi-modality imaging and radiogenomics
-
21:44
how to utilize mri for focal therapy planning
-
12:35
radiologic perspective on the clinical utility of and emerging data on micro-ultrasound
-
12:50
imaging tools for improving risk assessment and patient selection for biopsy
-
11:20
evaluation and management of localized and recurrent prostate cancer: genetic cancer profiling
-
11:04
radiogenomics in active surveillance how can we integrate mpmri and genomics to monitor pca
-
12:15
pet imaging for selection of focal therapy candidates
-
26:20
mapping pathology as a guide to focal therapy the role of mapping biopsies and tissue markers
-
12:03
mri-guided focal therapy: initial quality-of-life and oncologic outcomes
-
10:36
emerging role of psma imaging
-
22:27
highlights from the 5th global summit on precision diagnosis and treatment of prostate cancer
-
19:50
application of mri fusion biopsy results to focal therapy
-
18:45
pathologists perspective on focal therapy
-
5:01
the use of mri to determine the target for focal therapy
-
1:55
pi-rads standardization and risk assessment - recent advances and future plans
-
20:50
active surveillance 2021 - from bench to bedside